Asgard Therapeutics
Founded 2018 · 4 known investors
Asgard Therapeutics is a biotech company developing cancer immunotherapies using direct cell reprogramming and gene therapy, with a lead program (AT-108) built as an off-the-shelf gene therapy. Spun off from Lund University, it works in immuno-oncology.
BiotechHealthtech
Investors · 4
In the news
Frequently asked questions
- What does Asgard Therapeutics do?
- Asgard Therapeutics is a biotech company developing cancer immunotherapies using direct cell reprogramming and gene therapy, with a lead program (AT-108) built as an off-the-shelf gene therapy. Spun off from Lund University, it works in immuno-oncology.
- Who are Asgard Therapeutics's investors?
- Asgard Therapeutics's investors include Industrifonden, LU Innovation, Novo Holdings, Boehringer Ingelheim Venture Fund.